Lv11
94 积分 2026-08-06 加入
TAAR1 agonist reduces α-NETA induced dyskinesia
10小时前
已关闭
The TAAR5 agonist α-NETA causes dyskinesia in mice
10小时前
已完结
Role of MARK2 in the nervous system and cancer
3天前
已完结
Placebo and Nocebo Effects
30天前
已完结
A phase I, open-label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and various degrees of hepatic function
1个月前
已完结
Tardive Dyskinesia with Antipsychotic Medication in Children and Adolescents: A Systematic Literature Review
1个月前
已完结
Long-Term Safety and Efficacy of Initial and Repeat Treatment Courses With Zuranolone in Adult Patients With Major Depressive Disorder
2个月前
已完结
Clinical efficacy and safety of Zuranolone (SAGE-217) in individuals with major depressive disorder
2个月前
已完结
Novel drug treatments for schizophrenia
2个月前
已完结
皖公网安备34019202002308
